Cutler Group LP Protalix Bio Therapeutics, Inc. Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Put Options
2 transactions
Others Institutions Holding PLX
# of Institutions
70Shares Held
5.61MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$827,3830.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$820,6920.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$471,1970.0% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$431,6770.0% of portfolio
-
Gsa Capital Partners LLP London, X0401KShares$409,2680.03% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $50.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...